Ruxolitinib add-on in corticosteroid-ref ractory graft-vs-host disease after allogeneic stem cell transplantation: Results from a retrospective study on 38 Chinese patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.